Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neogenomics Inc
Long-Term Debt Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Long-Term Debt
$340m
CAGR 3-Years
-14%
CAGR 5-Years
29%
CAGR 10-Years
52%
Thermo Fisher Scientific Inc
NYSE:TMO
Long-Term Debt
$31.2B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
11%
Danaher Corp
NYSE:DHR
Long-Term Debt
$16.3B
CAGR 3-Years
-12%
CAGR 5-Years
0%
CAGR 10-Years
19%
Mettler-Toledo International Inc
NYSE:MTD
Long-Term Debt
$1.7B
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
18%
Agilent Technologies Inc
NYSE:A
Long-Term Debt
$2.1B
CAGR 3-Years
-8%
CAGR 5-Years
11%
CAGR 10-Years
0%
IQVIA Holdings Inc
NYSE:IQV
Long-Term Debt
$12.3B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
20%

See Also

What is Neogenomics Inc's Long-Term Debt?
Long-Term Debt
340m USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Long-Term Debt amounts to 340m USD.

What is Neogenomics Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
52%

Over the last year, the Long-Term Debt growth was -37%. The average annual Long-Term Debt growth rates for Neogenomics Inc have been -14% over the past three years , 29% over the past five years , and 52% over the past ten years .

Back to Top